Good story over at the Los Angeles Times today illustrating just how gnarly things can get when litigation ensues, even if you think you have the clear high ground going in.
The upshot: Major League Baseball has been very sharp in its legal briefs thus far saying what we all know: Frank McCourt is undercapitalized and has used his team as a personal cash cow. McCourt’s logical response: “I ain’t the only one.” And he’s likely to seek the financials from other teams to prove it. Bill Shaikin notes that the Marlins may be particularly interesting given how clearly Jeff Loria was steered into the ownership chair of that team and how little of the Marlins’ revenue sharing money has been spent for baseball purposes.
In other McCourt news, there was apparently a hearing in the case this morning. It was mostly about schedules and boring stuff like that, but apparently McCourt’s lawyers argued that the Dodgers’ late season play — they’re going to finish over .500 — and the fact that Clayton Kershaw and Matt Kemp are leading candidates for postseason awards vindicates his management of the team and shows that it has not been harmed.
I don’t think that gets him very far — the business health of the team is every bit as important, if not more so, than the baseball health for the purposes of this proceeding — but I’m gonna be really mad if Kemp and Kershaw are even partially responsible for McCourt holding on to the Dodgers. They’re two of my favorite players right now, but I don’t think that can remain the case if that happens.
It’s been a miserable weekend for Nationals’ outfielder Adam Eaton, who stumbled over first base and injured his leg while running out an infield single in Friday’s 4-3 win over the Mets. While the team officially placed the outfielder on the 10-day disabled list with a left knee strain on Saturday, FOX Sports’ Ken Rosenthal reports that Eaton has been diagnosed with a torn ACL in his left knee and is expected to miss the remainder of the 2017 season. The team has yet to confirm the diagnosis or announce a definite timetable for the 28-year-old’s return, perhaps due to extended evaluations by Eaton’s orthopedic doctor:
The Nationals appear to have several outfield options with Eaton on the disabled list, though they have not pinned down a long-term solution. Center fielder Michael Taylor replaced Eaton on the field during the tail end of Friday’s game, and returned on Saturday to man center and bat second in the lineup. The club also promoted top outfield prospect Rafael Bautista, who slashed .291/.325/.354 with five doubles and a .680 OPS through 19 games in Triple-A Syracuse this season. He’ll assume Eaton’s roster spot and looks to be available for a backup role in the outfield going forward.
Last we heard from Shelby Miller, the Diamondbacks’ right-hander was contemplating Tommy John surgery for a partial UCL tear in his right elbow. Now, he appears to have decided to go through with the procedure.
Miller decided to skip Tommy John alternatives like plasma-rich platelet injections or stem cell treatment, which have been used to varying degrees of success by other major league pitchers with similar injuries. The surgery will set him back an estimated 12-18 months, FanRag Sports’ Tommy Stokke reports, which puts Miller’s estimated return date somewhere in 2018 if all goes well.
The 26-year-old starter was off to a rocky start this season, posting a 2-2 record and 4.09 ERA through 22 innings and striking out just 20 of 99 batters faced. This was his sophomore campaign in Arizona after muddling through the 2016 season with a 3-12 record, 6.15 ERA and 0.5 fWAR over 101 innings with the club.